226 related articles for article (PubMed ID: 22875994)
1. Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells.
Allegra M; Zaragkoulias A; Vorgia E; Ioannou M; Litos G; Beug H; Mavrothalassitis G
Mol Biol Cell; 2012 Oct; 23(19):3873-81. PubMed ID: 22875994
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway.
Liu TJ; Guo JL; Wang HK; Xu X
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1035-1043. PubMed ID: 29509252
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells.
Arase M; Tamura Y; Kawasaki N; Isogaya K; Nakaki R; Mizutani A; Tsutsumi S; Aburatani H; Miyazono K; Koinuma D
Sci Rep; 2017 Apr; 7(1):1166. PubMed ID: 28446749
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.
Maschler S; Grunert S; Danielopol A; Beug H; Wirl G
Oncogene; 2004 Apr; 23(20):3622-33. PubMed ID: 15116096
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells.
Lee EK; Jeon WK; Chae MY; Hong HY; Lee YS; Kim JH; Kwon JY; Kim BC; Park SH
Biochem Biophys Res Commun; 2010 Jan; 391(1):1021-7. PubMed ID: 19968960
[TBL] [Abstract][Full Text] [Related]
6. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
[TBL] [Abstract][Full Text] [Related]
7. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ; Schiemann WP
Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
9. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
Ellenrieder V; Buck A; Harth A; Jungert K; Buchholz M; Adler G; Urrutia R; Gress TM
Gastroenterology; 2004 Aug; 127(2):607-20. PubMed ID: 15300592
[TBL] [Abstract][Full Text] [Related]
10. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
11. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M; Shintani Y; Wheelock MJ; Johnson KR
J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
[TBL] [Abstract][Full Text] [Related]
12. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin 7a aggravates TGF-β1-induced airway EMT through the FAK/ERK1/2 signaling pathway in asthma.
Peng H; Sun F; Jiang Y; Guo Z; Liu X; Zuo A; Lu D
Front Immunol; 2023; 14():1167605. PubMed ID: 38022556
[TBL] [Abstract][Full Text] [Related]
14. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
Zinn R; Otterbein H; Lehnert H; Ungefroren H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
16. Role of Sema4C in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
Zeng R; Han M; Luo Y; Li C; Pei G; Liao W; Bai S; Ge S; Liu X; Xu G
Nephrol Dial Transplant; 2011 Apr; 26(4):1149-56. PubMed ID: 20959347
[TBL] [Abstract][Full Text] [Related]
17. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Kim H; Choi JA; Kim JH
J Biol Chem; 2014 Aug; 289(32):22151-60. PubMed ID: 24990945
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 Induces EMT in Bovine Mammary Epithelial Cells Through the TGFβ1/Smad Signaling Pathway.
Chen Q; Yang W; Wang X; Li X; Qi S; Zhang Y; Gao MQ
Cell Physiol Biochem; 2017; 43(1):82-93. PubMed ID: 28848180
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro.
Xie L; Law BK; Chytil AM; Brown KA; Aakre ME; Moses HL
Neoplasia; 2004; 6(5):603-10. PubMed ID: 15548370
[TBL] [Abstract][Full Text] [Related]
20. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
Su J; Morgani SM; David CJ; Wang Q; Er EE; Huang YH; Basnet H; Zou Y; Shu W; Soni RK; Hendrickson RC; Hadjantonakis AK; Massagué J
Nature; 2020 Jan; 577(7791):566-571. PubMed ID: 31915377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
